Artiva Biotherapeutics Revenue and Competitors



Total Funding



Estimated Revenue & Valuation

  • Artiva Biotherapeutics's estimated annual revenue is currently $13.6M per year.(i)
  • Artiva Biotherapeutics's estimated revenue per employee is $155,000
  • Artiva Biotherapeutics's total funding is $198M.

Employee Data

  • Artiva Biotherapeutics has 88 Employees.(i)
  • Artiva Biotherapeutics grew their employee count by -7% last year.

Artiva Biotherapeutics's People

Cofounder & Strategic AdvisorReveal Email/Phone
VP, Regulatory Affairs & QualityReveal Email/Phone
VP, Clinical OperationsReveal Email/Phone
SVP, Research and Early DevelopmentReveal Email/Phone
Chief Medical OfficerReveal Email/Phone
Director FacilitiesReveal Email/Phone
Sr Director, Project and Alliance ManagementReveal Email/Phone
Senior Director, Pharmacology (Early Development)Reveal Email/Phone
Director Quality ControlReveal Email/Phone
Director Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

What Is Artiva Biotherapeutics?

At Artiva, our mission is to deliver to cancer patients highly effective cellular immunotherapies that are also safe and immediately accessible. Towards this end, Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies, that leverage the company’s unique manufacturing and engineering capabilities. Artiva is headquartered in San Diego.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Artiva Biotherapeutics News

2022-04-06 - Artiva Biotherapeutics Announces Agreement with Merck to ...

Artiva's platform supports large-scale production and cryopreservation of off-the-shelf allogeneic NK and CAR-NK therapeutics. About Artiva...

2022-04-06 - Rough biotech market won't stop 5AM Ventures' new $750M ...

... the firm invested in Artiva Biotherapeutics, a private developer of ... adding that 5AM primarily gravitates toward therapeutics...

2021-03-01 - Daily funding roundup - March 1st, 2021

Skydio raised $170M; Artiva landed $120M; FogPharma secured $107M; Axonius picks up $100M Skydio: Skydio is a Redwood City, Ca.-based autonomous drone-maker. Skydio has raised $170 million in Series D funding at a post-money valuation of more than $1 billion led by earlier investor Andreessen H ...

2021-03-01 - Artiva Biotherapeutics Finds $120M In Series B

San Diego-based biopharmaceuticals company Artiva Biotherapeutics has raised a big, $120M funding round, in its Series B funding, according to the company. The funding was led by Venrock Healthcare Capital Partners, and also included Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capi ...

2021-02-26 - Artiva Biotherapeutics, Inc. announced that it has received $120.000001 million in funding from a group of investors

On February 26, 2021, Artiva Biotherapeutics, Inc. closed the transaction. The company raised funding led by by new investor Venrock Healthcare Capital Partners, a fund managed by Venrock. The transaction included participation from other new investors Acuta Capital Partners LLC, Cormorant Asset ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding